Prevention of Elevation in Plasma Triacylglycerol with High-Dose Bezafibrate Treatment Abolishes Insulin Resistance and Attenuates Glucose Intolerance Induced by Short-Term Treatment with Dexamethasone in Rats

Table 1

The relative organ and tissue masses and hepatic glycogen data at the day of euthanasia.

	Ctl	Dexa	Beza	BezaDexa
^1Retroperitoneal fat	1.1 ± 0.3	1.1 ± 0.4	1.0 ± 0.4	1.1 ± 0.4
^1Epididymal fat	1.1 ± 0.2	1.3 ± 0.3	1.1 ± 0.3	1.2 ± 0.3
^1Visceral fat (both)	2.2 ± 0.4	2.4 ± 0.7	2.1 ± 0.7	2.3 ± 0.6
^2Spleen	193 ± 17	124 ± 9	200 ± 22	133 ± 16
^3Hepatic glycogen content	0.9 ± 0.5	4.6 ± 1.1	0.6 ± 0.2	0.7 ± 0.4^#

¹(g/100 g, b.m.); ²(mg/100 g, b.m.); ³(mg/g tissue), read methods for details. Results are expressed as mean ± SD. Significantly different vs. the respective control group (dexamethasone effect) and ^#significantly different vs. the respective control group (bezafibrate effect) using two-way ANOVA with Tukey’s post hoc test. –8, . 1 and 2 are equal to (g/b.m) × 100 or (mg/b.m.) × 100, respectively.